Article

Using the GAD-7 Scale in Multiple Sclerosis Patients

Analyzing the validity of anxiety testing


 

References

The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a reliable and valid measure of anxiety in patients with multiple sclerosis (MS), according to an analysis of the psychometric properties of the scale.

Researchers administered the GAD-7 to 513 patients, and randomly split the sample to conduct an exploratory and confirmatory factor analysis and found:

• The scale showed an acceptable internal consistency and was highly correlated with the Hospital Anxiety and Depression Scale–Anxiety.

• GAD-7 scores were higher in women and patients with secondary progressive MS.

• Higher GAD-7 scores were associated with more depressive symptoms.

Citation: Terrill AL, Hartoonian N, Beier M, Salem R, Alschuler K. The 7-item Generalized Anxiety Disorder Scale as a tool for measuring generalized anxiety in multiple sclerosis. Int J MS Care. 2015;17(2):49-56. doi: 10.7224/1537-2073.2014-008.

Recommended Reading

DECIDE: Daclizumab cuts MS relapse rate by 45%
MDedge Neurology
Experimental MS Drug May Repair Nerve Damage
MDedge Neurology
Can Coffee Reduce the Risk of MS?
MDedge Neurology
What Happens When Patients With MS Stop Taking Their Medication?
MDedge Neurology
Epilepsy Drug May Preserve Eyesight for Patients With MS
MDedge Neurology
Tips for Coping With Multiple Sclerosis
MDedge Neurology
Switch to Oral Fingolimod May Improve MS Outcomes
MDedge Neurology
Conference News Update—Federation of American Societies for Experimental Biology
MDedge Neurology
Can FLAIR MRI Show Treatment Efficacy?
MDedge Neurology
Robert Fox, MD
MDedge Neurology